Moxisylyte (hydrochloride)

Moxisylyte (hydrochloride) is (alpha 1-blocker) antagonist, it can vasodilates cerebral vessels without reducing blood pressure. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. [1][2]

Product Specifications

CAS Number

[964-52-3]

Product Name Alternative

Thymoxamine hydrochloride

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Adrenergic Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Cardiovascular Disease; Endocrinology

Assay Protocol

https://www.medchemexpress.com/Moxisylyte-hydrochloride.html

Concentration

10mM

Purity

99.96

Solubility

DMSO : 20 mg/mL (ultrasonic) |H2O : ≥ 50 mg/mL

Smiles

CC(C1=C(OCCN(C)C)C=C(C)C(OC(C)=O)=C1)C.[H]Cl

Molecular Formula

C16H26ClNO3

Molecular Weight

315.84

Precautions

H302, H315, H319, H335

References & Citations

[1]Ryuji Sakakibara et al. Are alpha-blockers involved in lower urinary tract dysfunction in multiple system atrophy? A comparison of prazosin and moxisylyte. 2000, March, 15, Pages 191-195.|[2]Marquer C et al. Moxisylyte: a review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use inimpotence. Fundam Clin Pharmacol, 1998, 12 (4) :377-87.